[go: up one dir, main page]

CY1116717T1 - A-I EXPERIMENTAL MIMICS - Google Patents

A-I EXPERIMENTAL MIMICS

Info

Publication number
CY1116717T1
CY1116717T1 CY20151100841T CY151100841T CY1116717T1 CY 1116717 T1 CY1116717 T1 CY 1116717T1 CY 20151100841 T CY20151100841 T CY 20151100841T CY 151100841 T CY151100841 T CY 151100841T CY 1116717 T1 CY1116717 T1 CY 1116717T1
Authority
CY
Cyprus
Prior art keywords
mimics
experimental
disorder
macro
peptides
Prior art date
Application number
CY20151100841T
Other languages
Greek (el)
Inventor
Jean-Louis Dasseux
Anna Shenderova Schwendeman
Lingyu Zhu
Original Assignee
Cerenis Therapeutics Holding Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10741801.4A external-priority patent/EP2396017B1/en
Application filed by Cerenis Therapeutics Holding Sa filed Critical Cerenis Therapeutics Holding Sa
Publication of CY1116717T1 publication Critical patent/CY1116717T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Παρέχονται πεπτίδια, συνθέσεις εξ' αυτών, και μέθοδοι για αγωγή ή πρόληψη της δυσλιπιδαιμίας, μιας καρδιαγγειακής πάθησης, της ενδοθηλιακής δυσλειτουργίας, μιας μακροαγγειακής διαταραχής, ή μιας μικροαγγειακής διαταραχής.Peptides, compositions thereof, and methods for treating or preventing dyslipidemia, a cardiovascular disease, endothelial dysfunction, a macro-vascular disorder, or a microvascular disorder are provided.

CY20151100841T 2009-02-16 2015-09-24 A-I EXPERIMENTAL MIMICS CY1116717T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15296009A 2009-02-16 2009-02-16
US15296209A 2009-02-16 2009-02-16
US15296609A 2009-02-16 2009-02-16
EP10741801.4A EP2396017B1 (en) 2009-02-16 2010-02-12 Apolipoprotein a-i mimics

Publications (1)

Publication Number Publication Date
CY1116717T1 true CY1116717T1 (en) 2017-03-15

Family

ID=58459787

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100841T CY1116717T1 (en) 2009-02-16 2015-09-24 A-I EXPERIMENTAL MIMICS

Country Status (1)

Country Link
CY (1) CY1116717T1 (en)

Similar Documents

Publication Publication Date Title
CY1118809T1 (en) APLIPOPROTEIN MIMICS A
DE602008002693D1 (en) VACCINE PEPTIDE COMBINATIONS AGAINST CATERING ALLERGY
EA201170242A1 (en) MODIFIED BULL POLYPEPTIDES G-CSF AND THEIR APPLICATION
BRPI0818288A2 (en) Conjugated proteins and peptides.
BRPI0817082A2 (en) Tear Implants and Related Methods
FR2941231B1 (en) NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES
MX379016B (en) COMPOSITIONS AND METHODS FOR TREATING GAUCHER'S DISEASE.
BRPI0813883A2 (en) STORAGE NETWORK WITH TARGET SIDE RECOGNITION AND ROUTE TABLE SENDING.
BRPI0809583A2 (en) modified fgf-21 polypeptides and their uses
DE602007002329D1 (en) Three-piece supporting prosthesis.
EA200802008A1 (en) PHARMACEUTICAL COMPOSITIONS
EA201101521A1 (en) METHODS OF TREATMENT OF ONCOLOGICAL DISEASES, USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
BRPI0911987A2 (en) sutures and coded heterofunctional methods.
BRPI0918652A2 (en) Pharmaceutical compositions and related release methods.
EP2401264A4 (en) PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
EP2176420A4 (en) DERIVED FROM VIRUS ANTIMICROBIAL PEPTIDES
EP3331573A4 (en) THERAPEUTIC CONJUGATES OF CELL INTERNALIZATION
BRPI1007929A2 (en) "methods and compositions for treating neovascularization".
ITRM20100186A1 (en) HIP REPLACEMENT.
BRPI0820794A2 (en) Resin composition, resin and textile
BRPI0917499A2 (en) pelvic implant delivery system, and, pelvic implant and delivery system
CY1114497T1 (en) METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF INTEGRITY
IT1392200B1 (en) MODULAR VERTEBRAL STABILIZER.
DK2294254T3 (en) Ultra-high molecular weight polyethylene yarn
FR2941232B1 (en) NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES